Literature DB >> 18941645

The use of two Amplatzer "Cribriform" Septal Occluders to close multiple postinfarction ventricular septal defects.

Malgorzata Szkutnik1, Jacek Kusa, Jacek Bialkowski.   

Abstract

Rupture of the interventricular septum is an uncommon and often fatal complication of myocardial infarction. Herein, we report the successful deployment of the Amplatzer Multi-Fenestrated Septal Occluder-"Cribriform" (AGA Medical Corporation; Plymouth, Minn) during 2 procedures to close multiple postinfarction ventricular septal defects in a severely ill patient. We show that, in selected patients who have multi-fenestrated multiple postinfarction ventricular septal defects, transcatheter implantation of the Amplatzer Cribriform Occluder can be a good therapeutic option.

Entities:  

Keywords:  Cardiac surgical procedures/instrumentation/methods; equipment design; heart rupture/classification/etiology/pathology; heart septal defects, ventricular/diagnosis/surgery; heart septum/pathology; myocardial infarction/complications; prosthesis implantation/instrumentation/methods; surgical procedures, minimally invasive; treatment outcome; ventricular septal rupture/etiology/therapy

Mesh:

Year:  2008        PMID: 18941645      PMCID: PMC2565523     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  12 in total

1.  Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder implant.

Authors:  P Pienvichit; T C Piemonte
Journal:  Catheter Cardiovasc Interv       Date:  2001-12       Impact factor: 2.692

2.  Multiple percutaneous VSD closures post-myocardial infarct.

Authors:  Ian Webb; Julian De Giovanni; David Hildick-Smith
Journal:  Eur Heart J       Date:  2006-03       Impact factor: 29.983

3.  Transcatheter management of ventricular septal rupture after myocardial infarction.

Authors:  M J Landzberg; J E Lock
Journal:  Semin Thorac Cardiovasc Surg       Date:  1998-04

4.  Transcatheter closure of a residual postmyocardial infarction ventricular septal defect with the Amplatzer septal occluder.

Authors:  E M Lee; D H Roberts; K P Walsh
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

5.  Transcatheter closure of post-myocardial infarction ventricular septal defect with Amplatzer septal occluder.

Authors:  A S Mullasari; C V Umesan; U Krishnan; S Srinivasan; M Ravikumar; H Raghuraman
Journal:  Catheter Cardiovasc Interv       Date:  2001-12       Impact factor: 2.692

Review 6.  Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: a case series.

Authors:  Jeffrey A Goldstein; Ivan P Casserly; David T Balzer; Richard Lee; John M Lasala
Journal:  Catheter Cardiovasc Interv       Date:  2003-06       Impact factor: 2.692

7.  [Post-infarction ventricular septal defect treated during the acute phase by transcatheter closure with an Amplatzer septal occluder].

Authors:  Josep Rodés-Cabau; Jaume Figueras; Carlos Peña; José Barrabés; Inocencio Anívarro; Jordi Soler-Soler
Journal:  Rev Esp Cardiol       Date:  2003-06       Impact factor: 4.753

8.  Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder- immediate results and up-to 5 years follow-up.

Authors:  M Demkow; W Ruzyllo; C Kepka; Z Chmielak; M Konka; Z Dzielinska; J Wilczynski; Z Juraszynski
Journal:  EuroIntervention       Date:  2005-05       Impact factor: 6.534

9.  Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: Results of a U.S. Registry.

Authors:  Ralf Holzer; David Balzer; Zahid Amin; Carlos E Ruiz; Jeffrey Feinstein; John Bass; Michael Vance; Qi-Ling Cao; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2004-02       Impact factor: 2.692

10.  Transcatheter closure of ventricular septal defects.

Authors:  J E Lock; P C Block; R G McKay; D S Baim; J F Keane
Journal:  Circulation       Date:  1988-08       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.